Innogen Pharmaceutical
Pioneering innovation in global pharmaceutical manufacturing and research.
Pioneering innovation in global pharmaceutical manufacturing and research.
Innogen Pharmaceutical is a pioneering force in global pharmaceutical manufacturing and research. With a focus on high-tech and innovation-driven approaches, the company has made significant strides in the Biopharma, Biotechnology, Manufacturing, and Pharmaceutical industries since its establishment in 2015. The recent Venture Round investment on 19 July 2022 has drawn attention, with prominent investors such as Korean Investment Partners, Hongtai Fund, Boyuan Capital, Lanting Capital, and Tongchuang Albert showing confidence in the company's vision and potential. Innogen Pharmaceutical's commitment to pioneering innovation sets it apart in the competitive pharmaceutical landscape, positioning it as a promising opportunity for venture capital investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
01 Jan 2024 |
| Venture Round | Unknown | 6 |
|
19 Jul 2022 |
| Series A | $120.00M | 3 |
|
23 Dec 2021 |
| Venture Round | Unknown | - | 22 Apr 2021 |
No recent news or press coverage available for Innogen Pharmaceutical.
-Limited.-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.